Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 17;10(8):e0135864.
doi: 10.1371/journal.pone.0135864. eCollection 2015.

Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan

Affiliations

Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan

Sung-Pin Tseng et al. PLoS One. .

Abstract

To investigate the efficacy of fosfomycin against extended-spectrum β-lactamases (ESBL) producing Escherichia coli in Taiwan and the resistance mechanisms and characterization of human and pig isolates, we analyzed 145 ESBL-producing isolates collected from two hospitals (n = 123) and five farms (n = 22) in Taiwan from February to May, 2013. Antimicrobial susceptibilities were determined. Clonal relatedness was determined by PFGE and multi-locus sequence typing. ESBLs, ampC, and fosfomycin resistant genes were detected by PCR, and their flanking regions were determined by PCR mapping and sequencing. The fosfomycin resistant mechanisms, including modification of the antibiotic target (MurA), functionless transporters (GlpT and UhpT) and their regulating genes such as uhpA, cyaA, and ptsI, and antibiotic inactivation by enzymes (FosA and FosC), were examined. The size and replicon type of plasmids carrying fosfomycin resistant genes were analyzed. Our results revealed the susceptibility rates of fosfomycin were 94% for human ESBL-producing E. coli isolates and 77% for pig isolates. The PFGE analysis revealed 79 pulsotypes. No pulsotype was found existing in both human and pig isolates. Three pulsotypes were distributed among isolates from two hospitals. ISEcp1 carrying blaCTX-M-group 9 was the predominant transposable elements of the ESBL genes. Among the thirteen fosfomycin resistant isolates, functionless transporters were identified in 9 isolates. Three isolates contained novel amino acid substitutions (Asn67Ile, Phe151Ser and Trp164Ser, Val146Ala and His159Tyr, respectively) in MurA (the target of fosfomycin). Four isolates had fosfomycin modified enzyme (fosA3) in their plasmids. The fosA3 gene was harboured in an IncN-type plasmid (101 kbp) in the three pig isolates and an IncB/O-type plasmid (113 kbp) in the human isolate. In conclusion, we identified that 6% and 23% of the ESBL-producing E. coli from human and pigs were resistant to fosfomycin, respectively, in Taiwan. No clonal spread was found between human and pig isolates. Functionless transporters were the major cause of fosfomycin resistance, and the fosA3-transferring plasmid between isolates warrants further monitoring.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. A dendrogram of pulsotype relationships developed via the unweighted pair group method using arithmetic averages (UPGMA) with BioNumerics software version 6.5 (Applied Maths).
Pulsotypes were assigned to the same clusters if they exhibited 80% similarity in the dendrogram. Three major clusters (XXIX, XXXIV, and XLIV) were found in two hospitals.
Fig 2
Fig 2. Representation of the sequences flanking fosA3.
Genes are shown as arrows with the direction of transcription indicated by the arrowheads.
Fig 3
Fig 3. PFGE analysis of fosA3-producing E. coli.
(A) S1-nuclease digested plasmid profiles separated by PFGE. (B) S1-nuclease digested plasmid profiles hybridized with a fosA3 probe. The arrows showed the location of fosA3 genes. (C) S1-nuclease digested plasmid profiles hybridized with a bla CTX-M-group 9 probe. The arrows showed the location of bla CTX-M-group 9 genes. Lane M, MidRange II PFG Marker; lane1, A10; lane 2, A11; lane 3, A12 and lane 4, K66.

References

    1. Pitout JD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8: 159–166. 10.1016/S1473-3099(08)70041-0 - DOI - PubMed
    1. Zahar JR, Lortholary O, Martin C, Potel G, Plesiat P, Nordmann P. (2009) Addressing the challenge of extended-spectrum beta-lactamases. Curr Opin Investig Drugs 10: 172–180. - PubMed
    1. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE (2010) Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10: 43–50. 10.1016/S1473-3099(09)70325-1 - DOI - PubMed
    1. Keating GM (2013) Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria. Drugs 73: 1951–1966. 10.1007/s40265-013-0143-y - DOI - PubMed
    1. Gutierrez L, Ocampo L, Rosario C, Sumano H (2010) Pharmacokinetics of disodium fosfomycin in broilers and dose strategies to comply with its pharmacodynamics versus Escherichia coli . Poult Sci 89: 2106–2115. 10.3382/ps.2010-00892 - DOI - PubMed

Publication types

MeSH terms